{"id":"https://openalex.org/W3172499701","doi":null,"title":"High rate of persistent symptom 4 months after community-managed COVID-19 infection","display_name":"High rate of persistent symptom 4 months after community-managed COVID-19 infection","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3172499701","mag":"3172499701"},"language":"en","primary_location":{"id":"mag:3172499701","doi":null,"is_oa":false,"landing_page_url":"https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/es/covidwho-1250074","pdf_url":null,"source":{"id":"https://openalex.org/S2765072364","display_name":"Topics in antiviral medicine","issn_l":"2161-5853","issn":["2161-5853","2161-5861"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","poland-100","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Topics in antiviral medicine","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015493481","display_name":"David Ross Darley","orcid":"https://orcid.org/0000-0002-9721-101X","observed_orcids":["https://orcid.org/0000-0002-9721-101X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D.R. Darley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052909853","display_name":"Gregory J. Dore","orcid":"https://orcid.org/0000-0002-4741-2622","observed_orcids":["https://orcid.org/0000-0002-4741-2622"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory J. Dore","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4741-2622","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042569029","display_name":"Lucette A. Cysique","orcid":"https://orcid.org/0000-0002-7711-6373","observed_orcids":["https://orcid.org/0000-0002-7711-6373"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lucette A. Cysique","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7711-6373","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043802956","display_name":"Joanna C. Masters","orcid":"https://orcid.org/0000-0002-2492-764X","observed_orcids":["https://orcid.org/0000-0002-2492-764X","https://orcid.org/0000-0002-7713-7916"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joanna C. Masters","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Andrew W. Byrne","orcid":"https://orcid.org/0000-0003-0296-4586","observed_orcids":["https://orcid.org/0000-0003-0296-4586"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew W. Byrne","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0296-4586","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023432955","display_name":"Bruce James Brew","orcid":"https://orcid.org/0000-0003-0622-1392","observed_orcids":["https://orcid.org/0000-0003-0622-1392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce J. Brew","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0622-1392","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083123263","display_name":"Paddy Cunningham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paddy Cunningham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Amy S. Kelleher","orcid":"https://orcid.org/0000-0002-1473-1272","observed_orcids":["https://orcid.org/0000-0002-1473-1272"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy S. Kelleher","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1473-1272","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110042414","display_name":"G Matthews","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Matthews","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.08605226,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"1","first_page":"209","last_page":"209"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11368","display_name":"Long-Term Effects of COVID-19","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11368","display_name":"Long-Term Effects of COVID-19","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.8199999928474426},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9290000200271606},{"id":"https://openalex.org/keywords/long-covid","display_name":"long COVID","score":0.7950000166893005},{"id":"https://openalex.org/keywords/persistent-fatigue","display_name":"persistent fatigue","score":0.8629999756813049},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.6489999890327454},{"id":"https://openalex.org/keywords/total-lung-capacity","display_name":"total lung capacity","score":0.7950000166893005},{"id":"https://openalex.org/keywords/diffusing-capacity-for-carbon-monoxide","display_name":"diffusing capacity for carbon monoxide","score":0.8600000143051147},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.8949999809265137},{"id":"https://openalex.org/keywords/anxiety-and-depression","display_name":"anxiety and depression","score":0.8560000061988831},{"id":"https://openalex.org/keywords/olfactory-dysfunction","display_name":"olfactory dysfunction","score":0.7129999995231628},{"id":"https://openalex.org/keywords/neurocognitive-impairment","display_name":"neurocognitive impairment","score":0.9750000238418579},{"id":"https://openalex.org/keywords/sars-cov-2-antibodies","display_name":"SARS-CoV-2 antibodies","score":0.878000020980835},{"id":"https://openalex.org/keywords/antibody-titers","display_name":"antibody titers","score":0.7300000190734863},{"id":"https://openalex.org/keywords/disease-severity","display_name":"disease severity","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9332539439201355},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5763621926307678},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5445615649223328},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5034844279289246},{"id":"https://openalex.org/C172467417","wikidata":"https://www.wikidata.org/wiki/Q1670397","display_name":"Neurocognitive","level":3,"score":0.49621039628982544},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.48663362860679626},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.46945542097091675},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.46264755725860596},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.45317158102989197},{"id":"https://openalex.org/C2776102371","wikidata":"https://www.wikidata.org/wiki/Q460030","display_name":"Community-acquired pneumonia","level":3,"score":0.43870487809181213},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4339233636856079},{"id":"https://openalex.org/C16020263","wikidata":"https://www.wikidata.org/wiki/Q1778553","display_name":"DLCO","level":5,"score":0.427674263715744},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.3743606209754944},{"id":"https://openalex.org/C165637977","wikidata":"https://www.wikidata.org/wiki/Q11067835","display_name":"Diffusing capacity","level":4,"score":0.30231785774230957},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.2479945719242096},{"id":"https://openalex.org/C3018587741","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung function","level":3,"score":0.22226691246032715},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.10160580277442932},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3172499701","doi":null,"is_oa":false,"landing_page_url":"https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/es/covidwho-1250074","pdf_url":null,"source":{"id":"https://openalex.org/S2765072364","display_name":"Topics in antiviral medicine","issn_l":"2161-5853","issn":["2161-5853","2161-5861"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","poland-100","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Topics in antiviral medicine","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3178055067","https://openalex.org/W3114086617","https://openalex.org/W4281780364","https://openalex.org/W4321793262","https://openalex.org/W7212006797","https://openalex.org/W3134251919","https://openalex.org/W4291143776","https://openalex.org/W4391219025","https://openalex.org/W3180810349","https://openalex.org/W4283783110"],"abstract_inverted_index":{"Background:":[0],"The":[1,13,81,157],"spectrum":[2],"of":[3,15,25,39,113,166,236,261,275,281,317,324],"recovery":[4],"following":[5,120],"community-managed":[6,121],"and":[7,23,30,69,74,90,97,124,127,153,169,249,283,309],"hospitalized":[8,128],"SARS-CoV-2":[9,32,63,270],"infection":[10,77,89,271],"remains":[11],"uncertain.":[12],"aim":[14],"the":[16,214,218,288,315,325],"ADAPT":[17,326],"study":[18,49,102,327],"was":[19,50,176,224],"to":[20,34,107,199,253,292,303],"determine":[21],"prevalence":[22,86,316],"nature":[24],"persistent":[26,136,160,264,297],"symptoms":[27,137,161,265,298,319],"after":[28,110,142,179,269,299],"community":[29,276],"hospitalised":[31],"infection;and":[33],"evaluate":[35],"lung":[36,173],"function;health-related":[37],"quality":[38],"life":[40],"(HRQOL);and":[41],"neurocognitive":[42],"abnormalities.":[43],"Methods:":[44],"A":[45,233,258],"prospective":[46],"observational":[47],"cohort":[48],"performed":[51,105],"at":[52,87,138,247,266,320],"St":[53],"Vincent's":[54],"Hospital":[55],"Sydney":[56],"Australia.":[57],"Adult":[58],"patients":[59,117,134,197,205,237,262],"with":[60,182,213,229,296],"a":[61],"positive":[62,240],"RNA":[64],"PCR":[65],"test":[66],"between":[67],"Mar-2020":[68],"Apr-2020":[70],"including":[71,146,272],"mild,":[72],"moderate,":[73],"severe":[75,129,149],"acute":[76,200,254],"were":[78,104,118,162,193,251,285],"offered":[79],"enrollment.":[80],"clinical":[82],"outcomes":[83],"included":[84],"symptom":[85],"initial":[88],"follow-up,":[91],"HRQOL":[92],"measures,":[93],"pulmonary":[94],"function,":[95],"neurocognition":[96],"COVID-19":[98,131,300],"antibody":[99,241],"responses.":[100],"Initial":[101],"assessments":[103],"up":[106],"4":[108,267],"months":[109,268],"first":[111],"detection":[112],"SARS-CoV-2.":[114],"Results:":[115],"Ninety-six":[116],"recruited":[119],"mild":[122,154],"(39%)":[123],"moderate":[125,151,219],"(50%),":[126],"(11%)":[130],"infection.":[132],"39.7%":[133],"had":[135],"median":[139],"72":[140],"days":[141],"diagnosis":[143],"(IQR":[144],"65-87),":[145],"those":[147,295],"in":[148,195,217],"(77.8%),":[150],"(33.3%),":[152],"(36.7%)":[155],"sub-populations.":[156],"most":[158],"common":[159],"fatigue":[163],"(28%),":[164],"shortness":[165],"breath":[167],"(25%)":[168],"cough":[170],"(21%).":[171],"Total":[172],"capacity":[174,188],"(TLC)":[175],"significantly":[177],"lower":[178],"severe,":[180],"compared":[181],"community-managed,":[183],"COVID-19,":[184],"p=0.05.":[185],"Abnormal":[186],"diffusion":[187],"for":[189],"carbon":[190],"monoxide":[191],"values":[192],"observed":[194],"16%":[196],"unrelated":[198],"illness":[201,255],"severity.":[202,256],"Twenty-four":[203],"percent":[204],"demonstrated":[206,239],"anxiety/depression,":[207],"as":[208],"measured":[209],"by":[210],"SPHERE-34":[211],"item,":[212],"highest":[215],"proportion":[216,235,260],"sub-population":[220],"(37%).":[221],"Neurocognitive":[222],"impairment":[223],"low":[225],"(9%)":[226],"but":[227],"associated":[228],"abnormal":[230],"olfaction":[231],"(p=0.02).":[232],"high":[234],"(77-85%)":[238],"responses,":[242],"on":[243,314],"four":[244],"commercial":[245],"assays,":[246],"follow-up":[248,291,323],"titres":[250],"related":[252],"Conclusion:":[257],"considerable":[259],"experience":[263],"one":[273],"third":[274],"managed":[277],"patients.":[278],"High":[279],"rates":[280],"depression":[282],"anxiety":[284],"reported":[286],"across":[287],"cohort.":[289],"Outpatient":[290],"further":[293,307],"assess":[294],"is":[301,328],"important":[302],"allow":[304],"multi-disciplinary":[305],"input,":[306],"investigation,":[308],"appropriate":[310],"management.":[311],"Data":[312],"collection":[313],"persisting":[318],"8":[321],"month":[322],"currently":[329],"underway.":[330]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-06-22T00:00:00"}